Stocks
Bone Biologics CorporationBBLG
NASDAQManufacturingBiotechnology$0.39
Price as of · delayed, not real-time
A developer of bone graft substitutes, this company focuses on a proprietary demineralized bone matrix technology for spinal fusion procedures. Its lead product candidate, BBT-1, is in clinical development, and investors track the stock for its exposure to the orthopedic medical device market.
52W Range: $0.38-$2.39
Congressional Interest in Bone Biologics Corporation (BBLG)
No congressional trades have been disclosed for Bone Biologics Corporation (BBLG) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading BBLG?
No congressional trades found for this stock.